Prevalence of Latent Tuberculosis Infection Among Hemodialysis Patients

ConditionsLatent Tuberculosis Infection End Stage Renal Disease (ESRD)Hemodialysis

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-100

SponsorSohag University

About this trial

This observational cross-sectional study aims to determine the prevalence of latent tuberculosis infection (LTBI) among patients undergoing regular hemodialysis at Sohag University Hospital, using the tuberculin skin test (TST). Identifying the burden of LTBI in this high-risk population will help guide early detection and preventive strategies

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

active TB patients

Trial population

Adult patients undergoing regular hemodialysis at Sohag University Hospital. The study will include patients aged 18 years and older who are clinically stable and able to undergo tuberculin skin testing

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

Tuberculin Skin Test (TST)
Diagnostic test
Intradermal injection of 5 unit (0.1 mm) of purified protein derivative (PPD) with measurement of induration after 48-72 hours.

Treatment groups

200 Participants

are divided into 1 treatment group

Group A: Hemodialysis Patients1 intervention

Trial outcomes

Primary outcomes

Prevalence of latent tuberculosis infection among hemodialysis patients.

Percentage of patients with positive tuberculin skin test (defined as induration ≥10 mm).

Time frame

Within 72 hours after TST administration.

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sohag University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: